The EU-funded SWEETOOLS project aims to improve our understanding of the role of sugars in human biology.
European Antibiotic Awareness Day 2017
Today we mark the 10th anniversary of the European Antibiotic Awareness Day, by raising awareness once more about the antimicrobial resistance (AMR) – one of the biggest threats to global health. Launched in June, the goal of the new One Health action plan is to preserve our ability to effectively treat infections in humans and animals. The key objectives are: 'Making the EU a best practice region'; 'Boosting research and innovation'; and 'Shaping the global agenda'. In addition, the Innovative Medicines Initiative is expected to call for research to understand the value of diagnostics and the obstacles to their uptake.
- Joint statement – Health Commissioner and Research Commissioner
- Health Research activities on antimicrobial resistance
- European Centre for Disease Prevention and Control – AMR portfolio
- EU action against antimicrobial resistance: EDCTP’s contribution
Directorate-General Research & Innovation and IMI at BIO-Europe 2017
DG Research & Innovation and the Innovative Medicines Initiative participated at the largest biotech event in Europe with a booth and a session. During this 3–day event, the booth attracted many visitors interested in the EU funding opportunities. Our session (EU funding for health research SMEs: the European Innovation Council and beyond) provided concrete examples of successful SME participation in EU–funded projects and informative insights and advice for applicants from EU policymakers.
- European Commission EU funding for health research SMEs
- Innovative Medicines Initiative
- European Innovation Council
- EIB Support in Life Sciences
- IMI beneficiary EBOMAN
Research & Innovation Projects for Policy (P4P) report on rare diseases online now
EU Framework Programmes have funded research on rare diseases for more than two decades. In FP7 and Horizon 2020, 164 projects have produced results and a selection of these were analysed in the context of the five policy challenges to develop five key policy recommendations.
The European and Developing Countries Clinical Trials Partnership – new calls open today
The latest quarterly EDCTP newsletter is out with information about the new calls and much more on past and future initiatives.
EU-funded project organises workshop on cancer diagnostics
The EUR 4.8 million EU-funded project Glass-Laser Multiplexed Biosensor (GLAM) organises the workshop ‘Key Enabling Technologies for Better Cancer Diagnosis’ on 7 November 2017 in Tel Aviv.
The project uses groundbreaking technology to develop a device that is a step towards truly personalised medicine. The photonic-based point-of-care device will help oncologists make better treatment decisions according to the patient’s needs in a non-invasive manner for cancer diagnosis. More on this and other interesting topics will be discussed during this workshop.
EUR 20 million EU funding to combat multi-drug resistant bacteria
The European Investment Bank and AntibioTx, a Danish biotech SME, signed a EUR 20m loan agreement to develop new antibiotic treatments for skin infections. The loan will co-finance clinical trials based on AntibioTX’ patent, the aim being to bring the product to the market in 2020-2021.
New action plan to foster development of advanced therapies
The European Commission and the European Medicines Agency (EMA) have published today a joint action plan to foster the development of advanced therapy medicinal products (ATMPs). The main aim is to streamline procedures and better address the specific requirements of ATMP developers. The Agency's Committee for Advanced Therapies plays a central role in the scientific assessment of ATMPs, as it provides the expertise needed to evaluate these medicines. Other initiatives include European Commission research programmes, the innovation offices in the national competent authorities and EMA’s PRIME scheme.
23-25 November 2017, Antwerp, Belgium - 6th International Fluid Academy Days (IFAD)
25-28 November 2017, Copenhagen, Denmark - 42nd World Small Animal Veterinary Congress and FECAVA 23rd Eurocongress